BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18948964)

  • 1. Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test.
    Soriguer F; García-Serrano S; García-Almeida JM; Garrido-Sánchez L; García-Arnés J; Tinahones FJ; Cardona I; Rivas-Marín J; Gallego-Perales JL; García-Fuentes E
    Obesity (Silver Spring); 2009 Jan; 17(1):10-5. PubMed ID: 18948964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
    Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
    Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous glucose tolerance test in childhood obesity: metabolite levels and their relation to glucose utilization rate (KG).
    Molnár D; Kardos M; Soltész G; Baranyai S
    Acta Paediatr Acad Sci Hung; 1982; 23(2):127-35. PubMed ID: 6753463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural estrous cycle in normal and diabetic bitches. II). Serum nonesterified fatty acids and serum free glycerol levels during glucose and insulin tests.
    Renauld A; Scaramal JD; Gómez NV; Márquez AG; Garrido D; Wanke MM
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):44-56. PubMed ID: 10797839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the effect of insulin on carbohydrate and lipid metabolism in obese subjects with normal glucose tolerance].
    Ratzmann VK; Wittig M; Krause G; Männchen E
    Z Gesamte Inn Med; 1975 Aug; 30(15):489-94. PubMed ID: 1189493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism.
    Pihlajamäki J; Karhapää P; Vauhkonen I; Kekäläinen P; Kareinen A; Viitanen L; Pesonen U; Kallio J; Uusitupa M; Laakso M
    Metabolism; 2003 May; 52(5):643-6. PubMed ID: 12759898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of weight reduction in obese diabetics and nondiabetics.
    Julius U; Schneider H; Leonhardt W; Hanefeld M; Gabsch HC
    Endokrinologie; 1976 Mar; 67(1):96-102. PubMed ID: 1244205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variation in serum nonesterified fatty acids during glucose tolerance test in undernourished patients with anorexia nervosa and in obese patients].
    Stephan F; Ghandour M; Réville P; de Laharpe F; Thierry R
    Sem Hop; 1977 Mar 16-23; 53(11-12):661-6. PubMed ID: 194319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
    Zancanaro C; Cigolini M; Bonora E; Moghetti P; Cacciatori V; Querena M; Muggeo M
    Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.
    Polyzogopoulou EV; Kalfarentzos F; Vagenakis AG; Alexandrides TK
    Diabetes; 2003 May; 52(5):1098-103. PubMed ID: 12716738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid mobilization in obesity without carbohydrate intolerance. 2. Caffeine-stimulated lipolysis].
    Ratzmann KP; Riemer D; Männchen E; Paul I
    Endokrinologie; 1976; 68(3):319-26. PubMed ID: 1009910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive symptoms and the glucose tolerance test and insulin tolerance test.
    Heninger GR; Mueller PS; Davis LS
    J Nerv Ment Dis; 1975 Dec; 161(6):421-32. PubMed ID: 1194911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity and diabetes. I. Blood sugar, blood insulin and NEFA during glucose tolerance test in obese subjects].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1969; 31(1):40-8. PubMed ID: 5402437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipolytic processes in obese subjects with different carbohydrate tolerance as estimated by means of determination of serum IRI, GH, FFA concentrations and blood lipidmobilizing activity during exercise test (author's transl)].
    Zietek J; Paluszak J; Ponikowska I; Bajon J; Kosowicz J; Porawska J
    Przegl Lek; 1980; 37(2):297-9. PubMed ID: 6988898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improvement of insulin sensitivity associated with the prolonged use of Acipimox in ++a morbid obese patient].
    Zura ML; Contreras P; Aguirre C; Araya V
    Rev Med Chil; 1994 Nov; 122(11):1298-302. PubMed ID: 7659902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects].
    Cordera R; De Micheli A; Maiello M; Odetti P; Viviani G; Prando R; Adezati L
    Minerva Dietol Gastroenterol; 1979; 25(3):347-52. PubMed ID: 400005
    [No Abstract]   [Full Text] [Related]  

  • 20. I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects.
    Prando R; Cordera R; De Micheli A; Maiello M; Odetti P; Viviani G; Corsi L; Adezati L
    Acta Diabetol Lat; 1978; 15(5-6):259-72. PubMed ID: 749494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.